Matthew Henn
Chief Tech/Sci/R&D Officer presso SERES THERAPEUTICS, INC.
Patrimonio netto: 49 099 $ in data 31/03/2024
Profilo
Matthew R.
Henn is currently the Chief Scientific Officer & Executive VP at Seres Therapeutics, Inc. He previously worked as a Director at Viral Genomics, Inc. and as a Director-Viral Genomics at The Broad Institute, Inc. Dr. Henn holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SERES THERAPEUTICS INC
0.04% | 16/02/2024 | 63 436 ( 0.04% ) | 49 099 $ | 31/03/2024 |
Posizioni attive di Matthew Henn
Società | Posizione | Inizio |
---|---|---|
SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 07/02/2019 |
Precedenti posizioni note di Matthew Henn
Società | Posizione | Fine |
---|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2012 |
Viral Genomics, Inc. | Director/Board Member | - |
Formazione di Matthew Henn
University of California, Berkeley | Doctorate Degree |
University of New Hampshire | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SERES THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Viral Genomics, Inc. | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Matthew Henn